Gregg L. Semenza
Gregg L. Semenza | |
|---|---|
Semenza in Stockholm, December, 2019 | |
| Born | Gregg Leonard Semenza July 12, 1956 New York City, U.S. |
| Education | Harvard University (AB) University of Pennsylvania (MD, PhD) |
| Known for | Hypoxia-inducible factors |
| Spouse | Laura Kasch-Semenza |
| Awards | Albert Lasker Award for Basic Medical Research (2016) Nobel Prize in Physiology or Medicine (2019) |
| Scientific career | |
| Institutions | Johns Hopkins School of Medicine |
| Thesis | Molecular genetic analysis of the silent carrier of beta thalassemia (haplotype) (1984) |
| Doctoral advisors | Elias Schwartz Saul Surrey |
Gregg Leonard Semenza (born July 12, 1956) is an American pediatrician and Professor of Genetic Medicine at the Johns Hopkins School of Medicine. He serves as the director of the vascular program at the Institute for Cell Engineering. He is a 2016 recipient of the Albert Lasker Award for Basic Medical Research. He is known for his discovery of HIF-1, which allows cancer cells to adapt to oxygen-poor environments. He shared the 2019 Nobel Prize in Physiology or Medicine for "discoveries of how cells sense and adapt to oxygen availability" with William Kaelin Jr. and Peter J. Ratcliffe. Semenza has had thirteen research papers retracted due to falsified data.